FDA — authorised 22 March 1971
- Marketing authorisation holder: BAXTER HLTHCARE
- Status: approved
🇺🇸 Sodium Lactate In Plastic Container in United States
FDA authorised Sodium Lactate In Plastic Container on 22 March 1971
Marketing authorisations
FDA — authorised 5 September 1984
- Application: NDA018947
- Marketing authorisation holder: HOSPIRA
- Local brand name: SODIUM LACTATE IN PLASTIC CONTAINER
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 21 April 1992
- Application: NDA020004
- Marketing authorisation holder: B BRAUN
- Local brand name: SODIUM LACTATE 1/6 MOLAR IN PLASTIC CONTAINER
- Indication: INJECTABLE — INJECTION
- Status: approved
Sodium Lactate In Plastic Container in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in United States
Frequently asked questions
Is Sodium Lactate In Plastic Container approved in United States?
Yes. FDA authorised it on 22 March 1971; FDA authorised it on 5 September 1984; FDA authorised it on 21 April 1992.
Who is the marketing authorisation holder for Sodium Lactate In Plastic Container in United States?
BAXTER HLTHCARE holds the US marketing authorisation.